Prague Med. Rep. 2023, 124, 5-15

https://doi.org/10.14712/23362936.2023.1

Janus Kinase Inhibitors in the Treatment of Alopecia Areata

Athanasios J. Stefanis

Department of Dermatovenerology, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic

Received September 11, 2022
Accepted January 13, 2023

Crossref Cited-by Linking

  • Starace Michela, Pampaloni Francesca, Lazaridou Elisabeth, Kyrmanidou Eirini, Stratigos Alexander, Lallas Aimilios, Katoulis Alexander, Sgouros Dimitrios, Quadrelli Federico, Rapparini Luca, Cedirian Stephano, Bruni Francesca, Ala Lorenzo, Rossi Alfredo, Piraccini Bianca Maria, Apalla Zoe: Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study. Dermatol Ther (Heidelb) 2024, 14, 953. <https://doi.org/10.1007/s13555-024-01141-z>
  • Stefanis Athanasios J., Dolezal Tomas, Gkalpakiotis Spyridon, Arenberger Petr: Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study. J of Cosmetic Dermatology 2024. <https://doi.org/10.1111/jocd.16666>
  • Rodenas-Herranz Teresa, Cebolla-Verdugo Marta, Llamas-Segura Carlos, Ruiz-Villaverde Ricardo, Herranz-Marín Maria Teresa: Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome. Dermato 2023, 3, 109. <https://doi.org/10.3390/dermato3020009>
Crossref Cited-by Linking logo